An Overview of Zantac Lawsuits—Know the Risks and Your Legal Options
On April 1st, 2020, the United States Food and Drug Administration (FDA) officially advised consumers, patients, and health care professionals to beware of the risks of prescription and over-the-counter Zantac (ranitidine). In addition, the FDA requested that all American drug manufacturers withdraw their Zantac products from the market. Depending on several different factors—including when and where they were manufactured and how they were stored—Zantac batches may contain harmful impurities.
The announcement came after a new round of studies found more evidence that many Zantac products are contaminated with N-Nitrosodimethylamine (NDMA)—a likely human carcinogen. The World Health Organization (WHO) considers NDMA to be a cancer-causing substance. While not every sample of the drug was contaminated, the impurities were consistent and persistent enough to demonstrate a significant risk to public health and safety. NDMA exposure has been linked to several life-threatening medical conditions, including:
- Stomach cancer;
- Bladder cancer;
- Small intestine cancer;
- Other types of cancers;
- Tumors of the kidneys and lungs; and
- Fibrosis of the liver.
If you or someone you know developed cancer or any other type of severe medical complications after taking prescription Zantac or over-the-counter Zantac, is it imperative that you consult with a qualified lawyer. You may have legal options available and a drug company may bear legal liability for the harm.